- Previous Close
917.95 - Open
948.95 - Bid 954.40 x --
- Ask 955.70 x --
- Day's Range
920.05 - 958.00 - 52 Week Range
420.00 - 1,183.00 - Volume
2,594 - Avg. Volume
15,240 - Market Cap (intraday)
21.25B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
39.44 - EPS (TTM)
24.23 - Earnings Date May 16, 2025 - May 20, 2025
- Forward Dividend & Yield 2.00 (0.22%)
- Ex-Dividend Date Jul 11, 2024
- 1y Target Est
--
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, clinical diagnostics, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
vimta.com1,428
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: VIMTALABS.BO
View MorePerformance Overview: VIMTALABS.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VIMTALABS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VIMTALABS.BO
View MoreValuation Measures
Market Cap
20.41B
Enterprise Value
20.23B
Trailing P/E
37.81
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.86
Price/Book (mrq)
5.96
Enterprise Value/Revenue
5.75
Enterprise Value/EBITDA
18.34
Financial Highlights
Profitability and Income Statement
Profit Margin
17.39%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.53B
Net Income Avi to Common (ttm)
545.93M
Diluted EPS (ttm)
24.23
Balance Sheet and Cash Flow
Total Cash (mrq)
277.88M
Total Debt/Equity (mrq)
3.39%
Levered Free Cash Flow (ttm)
--